kabutan

ONO PHARMA, 2% Increase in Net Income for The Current Fiscal Year

Fri May 8, 2026 12:00 pm JST Earnings

4528 ONO PHARMACEUTICAL CO., LTD. 【IFRS】

Earnings Report

ONO PHARMACEUTICAL CO., LTD. <4528> [TSE Prime] announced its financial results (based on IFRS) at noon (12:00) on May 8th. The consolidated net income for the fiscal year ended March 2026 expanded to 39.4% from the previous period to 69.7 billion yen. For the fiscal year ending March 2027, the consolidated net income is expected to grow by 1.8% to 71.0 billion yen.

In the most recent three-month period, from January to March (4Q), the consolidated net income/loss turned to a profit of 0.81 billion yen (compared to a loss of 6.54 billion yen in the same period last year). The operating profit/loss margin drastically improved from -9.8% in the same period last year to 3.3%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 502,672 159,935 163,734 127,977 266.6 80 May 9, 2024 IFRS
Mar, 2025 486,871 59,747 59,328 50,047 106.6 80 May 8, 2025 IFRS
Mar, 2026 515,785 92,236 92,654 69,767 148.5 80 May 8, 2026 IFRS
YoY +5.9% +54.4% +56.2% +39.4% +39.4%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2026 Guidance 490,000 85,000 85,000 67,000 142.6 80 May 8, 2025 IFRS
Mar, 2026 Results 515,785 92,236 92,654 69,767 148.5 80 May 8, 2026 IFRS
Revision Rate +5.3% +8.5% +9.0% +4.1% +4.1%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2025 257,136 52,069 52,175 40,089 85.3 40 Oct 30, 2025 IFRS
Apr - Sep, 2026 Guidance ー ー ー ー － 40 May 8, 2026 IFRS
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 486,871 59,747 59,328 50,047 106.6 80 May 8, 2025 IFRS
Mar, 2026 515,785 92,236 92,654 69,767 148.5 80 May 8, 2026 IFRS
Mar, 2027 Guidance 455,000 94,000 94,000 71,000 151.1 80 May 8, 2026 IFRS
YoY -11.8% +1.9% +1.5% +1.8% +1.8%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jan - Mar, 2025 112,309 -11,007 -12,709 -6,545 -13.9 -9.8 May 8, 2025 IFRS
Apr - Jun, 2025 127,536 21,995 22,650 17,673 37.6 17.2 Aug 1, 2025 IFRS
Jul - Sep, 2025 129,600 30,074 29,525 22,416 47.7 23.2 Oct 30, 2025 IFRS
Oct - Dec, 2025 139,900 36,223 37,202 28,860 61.4 25.9 Feb 2, 2026 IFRS
Jan - Mar, 2026 118,749 3,944 3,277 818 1.7 3.3 May 8, 2026 IFRS
YoY +5.7% － － － －

Related Articles